2 results match your criteria: "Unversity College London[Affiliation]"

Duplicated network meta-analysis in advanced prostate cancer: a case study and recommendations for change.

Syst Rev

December 2022

MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, Unversity College London, 90 High Holborn, London, WC1V 6LJ, UK.

Background: Research overlap and duplication is a recognised problem in the context of both pairwise and network systematic reviews and meta-analyses. As a case study, we carried out a scoping review to identify and examine duplicated network meta-analyses (NMAs) in a specific disease setting where several novel therapies have recently emerged: hormone-sensitive metastatic prostate cancer (mHSPC).

Methods: MEDLINE and EMBASE were systematically searched, in January 2020, for indirect or mixed treatment comparisons or network meta-analyses of the systemic treatments docetaxel and abiraterone acetate in the mHSPC setting, with a time-to-event outcome reported on the hazard-ratio scale.

View Article and Find Full Text PDF

Photodynamic therapy of cutaneous T-cell lymphoma cell lines mediated by 5-aminolevulinic acid and derivatives.

J Photochem Photobiol B

August 2021

Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP), CONICET-Hospital de Clínicas Gral, José de San Martín, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address:

The delta-amino acid 5-aminolevulinic acid (ALA), is the precursor of the endogenous photosensitiser Protoporphyrin IX (PpIX), and is currently approved for Photodynamic Therapy (PDT) of certain superficial cancers. However, ALA-PDT is not very effective in diseases in which T-cells play a significant role. Cutaneous T-cell lymphomas (CTCL) is a group of non-Hodgkin malignant diseases, which includes mycosis fungoides (MF) and Sézary syndrome (SS).

View Article and Find Full Text PDF